ROCK2-IN-10

CAS No. 1072906-07-0

ROCK2-IN-10( —— )

Catalog No. M37666 CAS No. 1072906-07-0

Benzenamine, 2-[2-(dimethylamino)ethoxy]-4-(1H-pyrazol-4-yl)- is a useful organic compound for research related to life sciences.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 185 In Stock
10MG 271 In Stock
25MG 427 In Stock
50MG 559 In Stock
100MG 749 In Stock
200MG 1014 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ROCK2-IN-10
  • Note
    Research use only, not for human use.
  • Brief Description
    Benzenamine, 2-[2-(dimethylamino)ethoxy]-4-(1H-pyrazol-4-yl)- is a useful organic compound for research related to life sciences.
  • Description
    Benzenamine, 2-[2-(dimethylamino)ethoxy]-4-(1H-pyrazol-4-yl)- is a useful organic compound for research related to life sciences. The catalog number is T9797 and the CAS number is 1072906-07-0.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1072906-07-0
  • Formula Weight
    246.31
  • Molecular Formula
    C13H18N4O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N1=CC(=CN1)C=2C=CC(N)=C(OCCN(C)C)C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • PDEC-NB

    PDEC-NB is a disulfide cleavable linker used for the antibody-drug conjugate?(ADC).

  • Bradykinin

    Bradykinin is an inflammatory mediator. It is a peptide that causes blood vessels to dilate (enlarge) via the release of prostacyclin, nitric oxide, and Endothelium-Derived Hyperpolarizing Factor. Bradykinin is a physiologically and pharmacologically active peptide of the kinin group of proteins, consisting of nine amino acids.

  • PF-06446846

    PF?06446846 is a potent and selective PCSK9 inhibitor?PF-06446846 reduces plasma PCSK9 and total cholesterol levels in rats following oral dosing.?